Quarterly report pursuant to Section 13 or 15(d)

Segment Reporting - Schedule of Revenues, Operating Expenses and Operating Income by Reportable Segment (Details)

v3.19.1
Segment Reporting - Schedule of Revenues, Operating Expenses and Operating Income by Reportable Segment (Details) - USD ($)
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Net revenue $ 15,080,211 $ 8,307,325
Direct operating costs 9,847,540 4,484,055
Selling and marketing 361,399 305,014
General and administrative 4,162,076 2,600,734
Research and development 254,656 255,880
Change in contingent consideration (64,203) 31,749
Depreciation and amortization 756,740 590,771
Total operating expenses 15,318,208 8,268,203
Operating income (loss) (237,997) $ 39,122
Healthcare IT [Member]    
Net revenue 12,119,744  
Direct operating costs 7,474,454  
Selling and marketing 351,951  
General and administrative 2,462,403  
Research and development 254,656  
Change in contingent consideration (64,203)  
Depreciation and amortization 677,987  
Total operating expenses 11,157,248  
Operating income (loss) 962,496  
Practice Management [Member]    
Net revenue 2,960,467  
Direct operating costs 2,373,086  
Selling and marketing 9,448  
General and administrative 396,370  
Research and development  
Change in contingent consideration  
Depreciation and amortization 78,753  
Total operating expenses 2,857,657  
Operating income (loss) 102,810  
Unallocated Corporate Expenses [Member]    
Net revenue  
Direct operating costs  
Selling and marketing  
General and administrative 1,303,303  
Research and development  
Change in contingent consideration  
Depreciation and amortization  
Total operating expenses 1,303,303  
Operating income (loss) $ (1,303,303)